OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Multiple strategies have been employed enhance antibody titer, such as process parameter optimization, media optimization, and the use of perfusion systems. Fine-tuning media composition plays a cr